<HashMap><database>ecrin-mdr-crc</database><scores/><additional><omics_type>Clinical</omics_type><study_start_year>2020</study_start_year><condition>Advanced Colorectal Cancer</condition><disease>Advanced Colorectal Cancer</disease><study_type>Observational</study_type><full_dataset_link>https://newmdr.ecrin.org/Study/2692583</full_dataset_link><location>China</location><study_start_month>4</study_start_month><repository>ECRIN MDR</repository><study_status>Recruiting</study_status></additional><is_claimable>false</is_claimable><name>Phase II Clinical Trial for PD-1 inhibitor with Metronomic chemotherapy for Advanced Colorectal Cancer with microsatellite stability (MSS)</name><description>Interventions: Case series:fPD-1 inhibitor with Metronomic chemotherapy
Primary outcome(s): Overall survival, OS;Progression-free survival, PFS
Study Design: Single arm</description><dates><creation>2020-04-15</creation></dates><accession>2692583</accession><cross_references><Chinese Clinical Trial Register>ChiCTR2000032079</Chinese Clinical Trial Register></cross_references></HashMap>